Samsara BioCapital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-308,151
| Closed | -$12.1M | – | 50 |
|
|
2023
Q2 | $12.1M | Sell |
308,151
-378,684
| -55% | -$13.4M | 2.13% | 9 |
|
|
2023
Q1 | $16.7M | Sell |
686,835
-121,206
| -15% | -$2.65M | 3.45% | 7 |
|
|
2022
Q4 | $17.3M | Hold |
808,041
| – | – | 3.72% | 7 |
|
|
2022
Q3 | $14.5M | Sell |
808,041
-202,010
| -20% | -$2.65M | 3.38% | 7 |
|
|
2022
Q2 | $9.72M | Sell |
1,010,051
-252,500
| -20% | -$3.17M | 2.59% | 9 |
|
|
2022
Q1 | $21.2M | Hold |
1,262,551
| – | – | 5.35% | 5 |
|
|
2021
Q4 | $21.1M | Sell |
1,262,551
-200,283
| -14% | -$3.28M | 4.1% | 7 |
|
|
2021
Q3 | $23.8M | Sell |
1,462,834
-662,537
| -31% | -$7.21M | 3.73% | 8 |
|
|
2021
Q2 | $13.4M | Sell |
2,125,371
-247,105
| -10% | -$1.59M | 1.66% | 14 |
|
|
2021
Q1 | $14.7M | Hold |
2,372,476
| – | – | 2.7% | 12 |
|
|
2020
Q4 | $16.4K | Sell |
2,372,476
-998,002
| -30% | -$6.39M | 1.65% | 9 |
|
|
2020
Q3 | $19M | Hold |
3,370,478
| – | – | 5.3% | 3 |
|
|
2020
Q2 | $17.2M | Buy |
3,370,478
+2,507,926
| +291% | +$10.4M | 5.53% | 7 |
|
|
2020
Q1 | $2.97M | Buy |
862,552
+162,552
| +23% | +$950K | 1.71% | 17 |
|
|
2019
Q4 | $6.01M | Buy |
+700,000
| New | +$2.5M | 2.88% | 11 |
|
Samsara BioCapital's ISEE Position: Q3 2023 in Review
Samsara BioCapital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 308,151 shares — an estimated $12.1M sold.
Samsara BioCapital first reported a position in ISEE in Q4 2019 and held it in 15 quarters. The position peaked at $23.8M in Q3 2021. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Samsara BioCapital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Samsara BioCapital sold 308,151 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $12.1M.
- Samsara BioCapital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 15 quarters.
- Samsara BioCapital's IVERIC bio, Inc. Common Stock position peaked at $23.8M in Q3 2021.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Samsara BioCapital's 13F filing for Q3 2023, filed 14 Nov 2023.